Camel's Milk as a Safe Alternative in Cow's Milk Allergy
This study has been completed.
Sponsor:
Meir Medical Center
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01223885
First received: October 10, 2010
Last updated: October 7, 2015
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
By performing a challenge with camel's milk in patients who are allergic to cow's milk, the investigators will examine if camel's milk is a safe alternative for these patients.
| Condition | Intervention |
|---|---|
|
Cow's Milk Allergy |
Dietary Supplement: Camel's milk |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Meir Medical Center:
Primary Outcome Measures:
- Development of allergic symptoms after graded oral challenge with camel's milk [ Time Frame: 3 hours follow-up after completion of the challenge ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 30 |
| Study Start Date: | December 2010 |
| Study Completion Date: | February 2013 |
| Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Camel's milk, Cow's milk allergy |
Dietary Supplement: Camel's milk
Patients with proved cow's milk allergy who have negative prick skin tests to came's milk will be administered gradually increased doses of pasteurized camel's milk at 30 minute intervals
|
Eligibility| Ages Eligible for Study: | Child, Adult, Senior |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Proved cow"s milk allergy
Exclusion Criteria:
- Pregnant women
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01223885
Please refer to this study by its ClinicalTrials.gov identifier: NCT01223885
Locations
| Israel | |
| Allergy Unit, Meir Medical Center | |
| Kfar-Saba, Israel, 44281 | |
Sponsors and Collaborators
Meir Medical Center
More Information
| Responsible Party: | Meir Medical Center |
| ClinicalTrials.gov Identifier: | NCT01223885 History of Changes |
| Other Study ID Numbers: | CM-MK-2 |
| Study First Received: | October 10, 2010 |
| Last Updated: | October 7, 2015 |
| Health Authority: | Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Hypersensitivity Milk Hypersensitivity Immune System Diseases Food Hypersensitivity Hypersensitivity, Immediate |
ClinicalTrials.gov processed this record on September 26, 2016